Thus, the present study aimed mainly to illustrate an additional mechanism through which EMPA could exert and potentiate its anti-inflammatory and anti-fibrotic effects using NASH rat model via targeting hepatic NF-κB/SOX 9/OPN axis and OCN. The gene discussed is BGLAP; the disease is metabolic dysfunction-associated steatohepatitis.